Preclinical characteristics of the irreversible pan- her kinase inhibitor neratinib compared with lapatinib: Implications for the treatment of HER2- positive and HER2-mutated breas...

بواسطة Collins, D.M., Conlon, N.T., Kannan, S., Verma, C.S., Eli, L.D., Lalani, A.S., Crown, J.
منشور في 2021